Bright Minds Biosciences Inc. (DRUG)

NASDAQ: DRUG · IEX Real-Time Price · USD

1.045

+0.005 (0.48%)

May 2, 2024, 4:00 PM EDT - Market closed

Bright Minds Biosciences Cash Flow Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2019
Net Income	-7.37	-14.96	-8.65	-0.48	-0.08
Depreciation & Amortization	0.07	0.01	0	0	0
Share-Based Compensation	1.15	0.88	1.25	0.16	0
Other Operating Activities	-0.88	0.5	0.08	0.03	0.04
Operating Cash Flow	-7.02	-13.59	-7.32	-0.29	-0.04
Share Issuance / Repurchase	1.22	4.35	27.76	1.01	0.12
Debt Issued / Paid	-0.09	-0.01	0	0	0
Other Financing Activities	1.06	0.85	-1.71	-	-
Financing Cash Flow	2.19	5.2	26.06	1.01	0.12
Exchange Rate Effect	-0.05	0.26	0.22	0	0
Net Cash Flow	-4.83	-8.39	18.74	0.72	0.08
Free Cash Flow	-7.02	-13.59	-7.32	-0.29	-0.04
Free Cash Flow Per Share	-1.89	-5.50	-4.08	-0.40	-0.10

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).